K-V Pharmaceutical Company today announced a new corporate name, Lumara Health Inc.

May, 29, 2014

 

K-V Pharmaceutical Company (“KV”) today announced the appointment of Janet Vergis to its Board of Directors

November 5, 2013

 

K-V Pharmaceutical Company (“KV”) today announced the appointment of two new members to its Board of Directors: Gregory Norden and James M. Goldfarb.

October 11, 2013

 

K-V Pharmaceutical Company (“KV”) today announced the appointment of Joseph M. Mahady as Chairman of its Board of Directors.

October 3, 2013

 

K-V Pharmaceutical Company (“KV”) today announced that its plan of reorganization (the “Plan”) has become effective and that it has successfully emerged from chapter 11 with significantly reduced debt and a $375 million recapitalization.

September 16, 2013